Welcome to On the Frontlines of Multiple Sclerosis, a ReachMD series with the latest education and information on diagnostic and prognostic advancements and treatment options for patients with Multiple Sclerosis.
ReachMD
ReachMD
ReachMD
ReachMD
ReachMD
ReachMD
W. Redd, E. Gutowski, N. Kumar
ReachMD
ReachMD
eViralHepatitis Review
Springer Healthcare
NeurologyLive
The GenerEhlist Team
ReachMD
American Heart Association
Ben Wilson
Core IM Team
Practice Point Communications
ReachMD
ReachMD
Michael Blaiss, MD
eMultipleSclerosis Review
Matthew Siuba
Boehringer-Ingelheim, Inc.
None
American Thoracic Society
ReachMD
ReachMD
Cleveland Clinic Heart & Vascular Institute
Mayo Clinic
Radcliffe Vascular
ReachMD
ReachMD
BMJ Group
Manthan and Jack
None
Medgeeks
By Richard Pescatore, DO, & Ali Raja, MD
VEIN Magazine
Pain Doctor Inc.
AGA
AGA
American Heart Association
ReachMD
Stephen Jenkins, MD, Austin Rupp, MD
St. Paul's Hospital
OffScrip Health
Clevleand Clinic Respiratory Institute
Delia Chiaramonte, MD
ePulmonology Review
Association for Elderly Medicine Education
Dr. Kaleem and Dr. Quigley
BioMérieux
Dr. Jamie Holloman
ReachMD
Dr. Bill Kortesis & Dr. Gaurav Bharti
ReachMD
Richard Elion, MD
ReachMD
ReachMD
None
Steve Carroll, DO
American College of Rheumatology
CardioNerds
CreakyJoints Australia
American Thoracic Society
ReachMD
www.rareshare.org, www.raregenomics.org
AMITA Health
Biohaven Pharmaceuticals
HMVJC
PulmPEEPs
Joe Chaffin, MD
Donald W. Crowe, MD
American Society of Hematology
American College of Emergency Physicians
Muhammad Yousaf and Ahmed Yousaf
Boehringer-Ingelheim, Inc.
ReachMD
None
Annenberg Center for Health Sciences
pituitaryworldnews
Continulus
Armin Kiankhooy, MD
BMJ Group
eHIV Review
Christopher Bryant
Jay Vipul Shah
BJA Education
ReachMD
Mayo Clinic Laboratories
Kristine Sufcak, MD
ReachMD
American Partnership for Eosinophilic Disorders